Finance

Lists
532488:BOM
Divi's Laboratories Ltd
၉,၂၂၀.၀၀ ₹
+၁.၉၉%
(+၁၈၀.၀၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၅၆:၁၅  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532488...
Open
၉,၀၁၃.၃၅ ₹
High
၉,၂၄၇.၅၀ ₹
Low
၈,၉၈၅.၀၀ ₹
Mkt. cap
ဋေ ၂.၄၅ သိန်း
Avg. vol.
၃.၃၇ သောင်း
Volume
၁.၇၂ သောင်း
Dividend
၀.၃၃%
Quarterly dividend
၇.၅၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၈၃.၆၇
52-wk high
၁၀,၀၀၀.၀၀ ₹
52-wk low
၅,၆၄၈.၀၀ ₹
EPS
၁၁၀.၂၀ ₹
Shares outstanding
၂၆.၅၅ ကုဋေ
No. of employees
၁ သောင်း
Open
၉,၀၁၃.၃၅ ₹
High
၉,၂၄၇.၅၀ ₹
Low
၈,၉၈၅.၀၀ ₹
Mkt. cap
ဋေ ၂.၄၅ သိန်း
Avg. vol.
၃.၃၇ သောင်း
Volume
၁.၇၂ သောင်း
Dividend
၀.၃၃%
Quarterly dividend
၇.၅၀ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၈၃.၆၇
52-wk high
၁၀,၀၀၀.၀၀ ₹
52-wk low
၅,၆၄၈.၀၀ ₹
EPS
၁၁၀.၂၀ ₹
Shares outstanding
၂၆.၅၅ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
Capital Brief
Capital Brief
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
Australian shares to open lower as chip selloff weighs on Nasdaq
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
AOL.com
·
ပြီးခဲ့သည့် ၈ နာရီ
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၇ နာရီ
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees၁.၁၆ သောင်း
Founded၁၉၉၀ အောက် ၁၂
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၁
Fiscal period
Q1 2027
၃၃.၉၅ ₹ / ၂၄.၆၈ ₹
+၃၇.၅၈%beat
Revenue / Est. (INR)
ဋေ ၃.၀၈ ထ / ဋေ ၂.၇၆ ထ
+၁၁.၅၆%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၂.၇၂ ထ
ဋေ ၂.၆၀ ထ
ဋေ ၂.၈၃ ထ
ဋေ ၃.၀၈ ထ
Cost of goods sold
ဋေ ၁.၀၇ ထ
၉၄၅.၀၀ ဋေ
ဋေ ၁.၃၅ ထ
၉၈၆.၀၀ ဋေ
Cost of revenue
ဋေ ၁.၀၇ ထ
၉၄၅.၀၀ ဋေ
ဋေ ၁.၃၅ ထ
၉၈၆.၀၀ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၅၄.၀၀ ဋေ
၃၆၇.၀၀ ဋေ
၃၉၉.၀၀ ဋေ
၄၀၈.၀၀ ဋေ
Operating expense
၈၆၇.၀၀ ဋေ
၈၈၇.၀၀ ဋေ
၆၆၈.၀၀ ဋေ
၉၆၅.၀၀ ဋေ
Total operating expenses
ဋေ ၁.၉၄ ထ
ဋေ ၁.၈၃ ထ
ဋေ ၂.၀၂ ထ
ဋေ ၁.၉၅ ထ
Operating income
၇၇၅.၀၀ ဋေ
၇၇၂.၀၀ ဋေ
၈၁၄.၀၀ ဋေ
ဋေ ၁.၁၃ ထ
Other non operating income
၈၂.၀၀ ကုဋေ
၆၉.၀၀ ကုဋေ
-၂၂၃.၀၀ ဋေ
၆၄.၀၀ ကုဋေ
EBT including unusual items
၉၁၂.၀၀ ဋေ
၇၈၀.၀၀ ဋေ
၉၆၃.၀၀ ဋေ
ဋေ ၁.၁၈ ထ
EBT excluding unusual items
၉၁၂.၀၀ ဋေ
၈၅၄.၀၀ ဋေ
၉၅၉.၀၀ ဋေ
ဋေ ၁.၁၈ ထ
Income tax expense
၂၂၃.၀၀ ဋေ
၁၉၇.၀၀ ဋေ
၂၁၂.၀၀ ဋေ
၂၇၈.၀၀ ဋေ
Effective tax rate
၂၄.၄၅%
၂၅.၂၆%
၂၂.၀၁%
၂၃.၅၆%
Other operating expenses
၄၀၀.၀၀ ဋေ
၄၀၂.၀၀ ဋေ
၁၄၉.၀၀ ဋေ
၄၂၄.၀၀ ဋေ
Net income
၆၈၉.၀၀ ဋေ
၅၈၃.၀၀ ဋေ
၇၅၁.၀၀ ဋေ
၉၀၂.၀၀ ဋေ
Net profit margin
၂၅.၃၈%
၂၂.၃၉%
၂၆.၅၃%
၂၉.၂၉%
Earnings per share
၂၅.၉၇
၂၄.၀၇
၂၈.၃၁
၃၃.၉၅
Interest and investment income
-
-
၂၈၄.၀၀ ဋေ
-
Interest expense
-၈.၀၀ ကုဋေ
-၆.၀၀ ကုဋေ
-၆.၀၀ ကုဋေ
-၆.၀၀ ကုဋေ
Net interest expenses
-၈.၀၀ ကုဋေ
-၆.၀၀ ကုဋေ
၂၇၈.၀၀ ဋေ
-၆.၀၀ ကုဋေ
Depreciation and amortization charges
၁၁၃.၀၀ ဋေ
၁၁၈.၀၀ ဋေ
၁၂၀.၀၀ ဋေ
၁၃၃.၀၀ ဋေ
EBITDA
၈၈၇.၅၀ ဋေ
၈၇၁.၅၀ ဋေ
၉၂၉.၀၀ ဋေ
ဋေ ၁.၂၄ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ